Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

New schools, restructuring part of streamlined Faculty of Health Sciences
2017-10-12

 Description: Health Sciences staff 2 Tags: Faculty of Health Sciences, five-school structure, Prof Gert van Zyl, Pathology, Biomedical Sciences  

From the left, front are: Dr Jocelyn Naicker,
Prof Gert van Zyl, Prof Magda Mulder;
back from left: Prof Chris Viljoen,
Marlene Viljoen, Deputy Director: Faculty of Health Sciences;
Prof Nathaniel Mofolo; and Prof Santie van Vuuren.
Photo: Rulanzen Martin


Numerous developments, such as the creation of two new schools and one newly restructured School of Medicine in the Faculty of Health Sciences at the University of the Free State (UFS), will catapult this renowned faculty to even greater heights.

Five-school structure to increase access
 
A five-school structure was proposed at the annual Faculty Management retreat in July 2016. The previous three-school model included the Schools of Medicine, Nursing, and Allied Health Professions.

The current School of Medicine has been restructured and will henceforth be known as the School of Clinical Medicine. The Schools of Pathology and Biomedical Sciences have been added to the faculty. “So, three new schools were in fact created within the faculty,” said Prof Gert van Zyl, Dean of the faculty.   

“There was also a request from the National Health Laboratory Services to group academics that is rendering services in pathology into a new School of Pathology.” This is what motivated the faculty management to create two new schools.

Esteemed academics appointed 

With the creation of the new schools, there were also new appointments within the Faculty of Health Sciences. Dr Jocelyn Naicker has been appointed as the new part-time Head of the School of Pathology, Prof Chris Viljoen was appointed as the part-time Head of the School of Biomedical Sciences, and Prof Nathaniel Mofolo as the new Head of the School of Clinical Medicine. Prof Santie van Vuuren remains Head of the School of Allied Health Professions, and Prof Magda Mulder as the head of the School of Nursing. 

Research outputs to remain as usual
The addition of the new schools will not impact research output. “In the past, research was done across departmental boundaries between all the departments in the faculty,” Prof Van Zyl said. The advantages of adding two additional schools are that the workload will be distributed among the five schools. The heads of schools will work within their respective disciplines and related areas, and will eliminate the duplication of administrative functions.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept